Medindia

X

TorreyPines Therapeutics to Host First Quarter 2008 Results Conference Call and Webcast

Tuesday, May 13, 2008 General News J E 4
Advertisement
LA JOLLA, Calif., May 12 TorreyPinesTherapeutics, Inc. (Nasdaq: TPTX) today announced that the company willconduct a conference call and audio webcast on Tuesday, May 13, 2008 at11:00 a.m., Eastern Time (ET), in conjunction with the release of itsfinancial results for the first quarter ended March 31, 2008. TorreyPinesanticipates releasing its financial results at 7:30 a.m. ET on Tuesday,May 13, 2008.

To participate in this conference call, dial 719-325-4817, confirmationcode 2644321 shortly before 11:00 a.m. ET. A replay of the call will beavailable from 2:00 p.m. ET. The replay number is 719-457-0820, confirmationcode 2644321. The audio webcast can be accessed at:http://www.torreypinestherapeutics.com.

About TorreyPines Therapeutics

TorreyPines Therapeutics, Inc. is a biopharmaceutical company committed toproviding patients with better alternatives to existing therapies through theresearch, development and commercialization of small molecule compounds. Thecompany's goal is to develop versatile product candidates each capable oftreating a number of acute and chronic diseases and disorders such asmigraine, chronic pain, muscle spasticity and rigidity, xerostomia andcognitive disorders. The company is currently developing four productcandidates: two ionotropic glutamate receptor antagonists and two muscarinicreceptor agonists. Further information is available athttp://www.torreypinestherapeutics.com.Company Contact: Media Contact: Craig Johnson David Schull TorreyPines Therapeutics, Inc. Russo Partners, LLC 858-623-5665, x118 212-845-4271 cjohnson@torreypinestherapeutics.com david.schull@russopartnersllc.com Investor Contact: Rhonda Chiger Rx Communications 917-322-2569 chiger@rxir.com

SOURCE TorreyPines Therapeutics, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
TorreyPines Therapeutics to Host First Quarter 200...
S
34 SEIU Healthcare Leaders Urge UHW-W Members to J...